These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Use of beta-cyclodextrin on the pharmaceutics of a volatile oil from a Chinese medicine: 2 inclusion methods]. Li SZ Zhong Yao Tong Bao; 1986 Dec; 11(12):31-3. PubMed ID: 2952338 [No Abstract] [Full Text] [Related]
7. Interaction of some benzothiadiazine diuretics with beta-cyclodextrin. Abdel-Rahman SI; el-Sayed AM Acta Pharm Hung; 1990 May; 60(2-3):69-75. PubMed ID: 2386074 [TBL] [Abstract][Full Text] [Related]
8. [Molecular cavity filling and tabletting with beta-cyclodextrin]. Hüttenrauch R; Fricke S Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643 [No Abstract] [Full Text] [Related]
9. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets]. Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749 [No Abstract] [Full Text] [Related]
10. [Spray embedding of vinpocetin with beta-cyclodextrin]. Kata M; György E Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372 [No Abstract] [Full Text] [Related]
11. [Application of beta-cyclodextrin during direct pressing of tablets]. Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849 [TBL] [Abstract][Full Text] [Related]
12. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution. Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072 [No Abstract] [Full Text] [Related]
13. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin. Kata M; Lukács M Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397 [No Abstract] [Full Text] [Related]
14. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex]. Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810 [No Abstract] [Full Text] [Related]
15. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation. Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671 [No Abstract] [Full Text] [Related]
16. [Inclusion compounds of 8 Chinese medicinal volatile oils with beta-cyclodextrin]. Li SZ; Guan SJ Zhong Yao Tong Bao; 1987 Dec; 12(12):27-32, 58-9. PubMed ID: 3446391 [No Abstract] [Full Text] [Related]
18. [Possible utility of beta-cyclodextrin complexation in the preparation of biphenyl acetic acid suppositories]. Uekama K; Maeda T; Arima H; Irie T; Hirayama F Yakugaku Zasshi; 1986 Dec; 106(12):1126-30. PubMed ID: 3559906 [No Abstract] [Full Text] [Related]
19. Enhancement of solubility of furosemide with beta-cyclodextrin. Kata M; Antal A Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396 [No Abstract] [Full Text] [Related]
20. Production and investigating of tablets containing furosemide and beta-cyclodextrin. Kata M; Haragh L; Pintye-Hódi K Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]